Daniel Grant Clark serves as Executive at Kiromic Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Daniel Grant Clark has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 11, 2022 involved receiving (via award) 50,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 11, 2022 | KRBP | $0 | Award | 50,000 | $N/A | Discretionary |
Daniel Grant Clark currently holds 62,770 shares of Kiromic Biopharma, Inc. (KRBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Grant Clark has been a net neutral trader of KRBP stock. They have purchased $0 and sold $0 worth of shares.
Daniel Grant Clark's most recent insider trade was on Aug 11, 2022, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted